학술논문
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
Document Type
Article
Author
Source
In JACC: Basic to Translational Science December 2021 6(12):935-945
Subject
Language
ISSN
2452-302X